Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison
- PMID: 8977343
- PMCID: PMC1383311
- DOI: 10.1136/gut.39.2.273
Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison
Abstract
Background: In patients with the Zollinger-Ellison syndrome, the exclusion of multiple endocrine neoplasia type 1 is of important clinical relevance. Its diagnosis often relies on the existence of primary hyperparathyroidism.
Aim and methods: To investigate the parathyroid function of patients with the Zollinger-Ellison syndrome by use of an oral calcium tolerance test to identify both hypercalcaemic and normocalcaemic primary hyperparathyroidism, and, accordingly, multiple endocrine neoplasia type 1.
Patients: Among 51 consecutive patients with the Zollinger-Ellison syndrome referred to us between 1988 and 1994, 28 had not been investigated for parathyroid function and were prospectively studied.
Results: The investigation of calcium metabolism was abnormal in nine patients. One displayed characteristic features of humoral hypercalcaemia of malignancy. The diagnosis of primary hyperparathyroidism was biologically established in eight patients (29%) and subsequently confirmed by the presence of hyperplasia of the parathyroid glands in the seven patients who underwent neck exploration. Three patients with primary hyperparathyroidism had fasting hyper-calcaemia but the other five had normal fasting serum total calcium concentration and the diagnosis of primary hyperparathyroidism was established by means of the oral calcium tolerance test. Primary hyperparathyroidism was demonstrated in the five patients in whom the diagnosis of multiple endocrine neoplasia type 1 had been previously established on other criteria than primary hyperparathyroidism. By contrast, in three patients, primary hyperparathyroidism, either hypercalcaemic (one patient) or normocalcaemic (two patients) was the sole criteria for the diagnosis of multiple endocrine neoplasia type 1. These results also suggest that primary hyperparathyroidism is present before or close to the time of Zollinger-Ellison syndrome diagnosis.
Conclusion: Complete investigation of the parathyroid function with calcium calcium and parathyroid hormone concentrations.
Similar articles
-
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).Gastroenterology. 1999 Feb;116(2):286-93. doi: 10.1016/s0016-5085(99)70124-1. Gastroenterology. 1999. PMID: 9922308
-
[Multiple endocrine neoplasms associated with Zollinger-Ellison syndrome and hyperparathyroidism].Ann Gastroenterol Hepatol (Paris). 1984 Jul-Sep;20(4):199-201. Ann Gastroenterol Hepatol (Paris). 1984. PMID: 6152141 French.
-
Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.Q J Med. 1980 Winter;49(193):69-76. Q J Med. 1980. PMID: 6107954
-
[Diagnostic and therapeutic strategy of Zollinger-Ellison syndrome. Groupe de Recherches et d'Etudes du Syndrome de Zollinger-Ellison (GRESZE)].Ann Chir. 1994;48(6):535-46. Ann Chir. 1994. PMID: 7847702 Review. French.
-
Growth hormone overproduction in a patient with multiple endocrine neoplasia type I.J Intern Med. 2000 Dec;248(6):525-30. doi: 10.1046/j.1365-2796.2000.00769.x. J Intern Med. 2000. PMID: 11155146 Review.
Cited by
-
Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test.J Endocrinol Invest. 2003 Apr;26(4):327-32. doi: 10.1007/BF03345180. J Endocrinol Invest. 2003. PMID: 12841540 Clinical Trial.
-
Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).Gut. 1997 Jul;41(1):107-14. doi: 10.1136/gut.41.1.107. Gut. 1997. PMID: 9274481 Free PMC article.
-
The chloride/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals.Sci Rep. 2017 Jul 7;7(1):4868. doi: 10.1038/s41598-017-05183-6. Sci Rep. 2017. PMID: 28687737 Free PMC article.
-
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.Cancer. 2008 Oct 1;113(7 Suppl):1807-43. doi: 10.1002/cncr.23648. Cancer. 2008. PMID: 18798544 Free PMC article. Review.
-
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.Neuroendocrinology. 2012;95(2):98-119. doi: 10.1159/000335591. Epub 2012 Feb 15. Neuroendocrinology. 2012. PMID: 22261919 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources